AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of EUR 341.33 billion. The enterprise value is 401.36 billion.

Market Cap	341.33B
Enterprise Value	401.36B

Important Dates

The last earnings date was Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	Jan 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.76B

Valuation Ratios

The trailing PE ratio is 83.38.

PE Ratio	83.38
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.80, with an EV/FCF ratio of 23.30.

EV / Earnings	98.05
EV / Sales	7.45
EV / EBITDA	15.80
EV / EBIT	23.54
EV / FCF	23.30

Financial Position

The company has a current ratio of 0.66, with a Debt / Equity ratio of 20.29.

Current Ratio	0.66
Quick Ratio	0.43
Debt / Equity	20.29
Debt / EBITDA	2.57
Debt / FCF	3.83
Interest Coverage	6.35

Financial Efficiency

Return on equity (ROE) is 62.29% and return on invested capital (ROIC) is 15.62%.

Return on Equity (ROE)	62.29%
Return on Assets (ROA)	8.25%
Return on Invested Capital (ROIC)	15.62%
Return on Capital Employed (ROCE)	18.49%
Revenue Per Employee	989,327
Profits Per Employee	74,427
Employee Count	55,000
Asset Turnover	0.42
Inventory Turnover	4.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.79% in the last 52 weeks. The beta is 0.56, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	+15.79%
50-Day Moving Average	174.09
200-Day Moving Average	168.86
Relative Strength Index (RSI)	75.15
Average Volume (20 Days)	899

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.17

Income Statement

In the last 12 months, AbbVie had revenue of EUR 54.41 billion and earned 4.09 billion in profits. Earnings per share was 2.31.

Revenue	54.41B
Gross Profit	38.26B
Operating Income	17.21B
Pretax Income	3.59B
Net Income	4.09B
EBITDA	25.31B
EBIT	17.21B
Earnings Per Share (EPS)	2.31

Full Income Statement

Balance Sheet

The company has 5.37 billion in cash and 65.92 billion in debt, giving a net cash position of -60.56 billion.

Cash & Cash Equivalents	5.37B
Total Debt	65.92B
Net Cash	-60.56B
Net Cash Per Share	n/a
Equity (Book Value)	3.25B
Book Value Per Share	1.82
Working Capital	-12.72B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 18.16 billion and capital expenditures -940.79 million, giving a free cash flow of 17.22 billion.

Operating Cash Flow	18.16B
Capital Expenditures	-940.79M
Free Cash Flow	17.22B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.31%, with operating and profit margins of 31.64% and 7.59%.

Gross Margin	70.31%
Operating Margin	31.64%
Pretax Margin	6.60%
Profit Margin	7.59%
EBITDA Margin	46.52%
EBIT Margin	31.64%
FCF Margin	31.65%

Dividends & Yields

This stock pays an annual dividend of 5.88, which amounts to a dividend yield of 3.04%.

Dividend Per Share	5.88
Dividend Yield	3.04%
Dividend Growth (YoY)	7.17%
Years of Dividend Growth	6
Payout Ratio	257.71%
Buyback Yield	-0.06%
Shareholder Yield	3.03%
Earnings Yield	1.20%
FCF Yield	5.05%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.08. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.08
Piotroski F-Score	n/a